Diagnostic value of serum tumor markers in asymptomatic individuals

Journal of B.U.ON.

Volumn 14, Issue 4, 2009, Pages 707-710

  Eleftheriadis, N ^a   Papaloukas, C ^a   Pistevou Gompaki, Kiki ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alpha fetoprotein; CEA; Normal individual; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EXAMINATION; COLON POLYP; COLONOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; PREDICTION; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 75149113271     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hanke B, Riedel C, Lampert S et al. CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA). Ann Oncol 2001 ; 12:221-226.
2. Wang WS, Lin JK, Lin TC et al. Carcinoembryonic antigen in monitoring of response to systemic chemotherapy in patients with metastatic colorectal cancer. Int J Colorectal Dis 2001;16:96-101.
3. Sandler B, Smirnoff P, Shani A et al. The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients. Anticancer Res 1999; 19(5B): 4229-4233.
4. Di Bisceglie AM, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 1989; 15; 64:2117-2120.
5. Cedrone A, Covino M, Caturelli E et al. Utility of alpha-feto-protein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology 2000; 47:1654-1658.
6. Klepp O. Serum tumour markers in testicular and extragonadal germ cell malignancies. Scand J Clin Lab Invest Suppl 1991;206:28-41.
7. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343:162-168.
8. Rundle AG, Lebwohl B, Vogel R, Levine S, Neugut AI. Colonoscopic screening in average-risk individuals ages 40 to 49 vs. 50 to 59 years. Gastroenterology 2008; 134:1311-1315.
9. Mihalko SL. Implementation of colonoscopy for mass screening for colon cancer and colonic polyps: efficiency with high quality of care. Gastroenterol Clin North Am 2008; 37:117-128.
10. Flanagan FL, Dehdashti F, Ogunbiyi OA, Kodner IJ, Siegel BA. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg 1998;227:319-323.